The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...
Single-ascending dose portion of study has successfully completed 2.5 and 7 mg / kg levelsDose dependent immunosuppressive ...
EVOLVE104, a First-in-Class CD2 Costimulatory Trispecific T Cell Engager, is First Molecule from EVOLVE Platform to Enter the Clinic ...
The B-cell depleting therapy is indicated for adults with generalized myasthenia gravis and anti-acetylcholine receptor or ...
“Following the initial pause, the FDA has placed the trial on a partial clinical hold,” the spokesperson explained.
Neoantigen vaccines are at the forefront of cancer research, driving personalized immunotherapy and improving outcomes ...
From vitamin C to your microbiome and mindset, the latest science of immunity is often counterintuitive. Here's how to give ...
MedPage Today on MSN
Gene Therapy-Induced CAR T Cells for Myeloma Could Alter Treatment Landscape
ORLANDO -- A gene therapy that could transform CAR T-cell treatment achieved rapid and potentially durable measurable residual disease (MRD)-negative responses in the first four patients with relapsed ...
Dana White has been ordered to testify in an ongoing antitrust lawsuit against the UFC.
Teclistamab (Tecvayli) is an off-the-shelf first-in-class bispecific monoclonal antibody shown in the MajesTEC-1 trial to ...
County supervisors this week approved $3.5 million to remove the bunks, which state inspectors have repeatedly ordered the ...
Over 1.5 million people globally experience gradual vision loss due to retinitis pigmentosa (RP). This condition comprises a group of inherited eye disorders characterized by the degeneration of cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback